Navigation Links
Pathwork Diagnostics Collaborates With Guy's and St Thomas' on Tissue of Origin Test Validation in the UK
Date:12/9/2008

London Hospitals First in UK to Perform Study Utilizing Pathwork Tissue of Origin Test

SUNNYVALE, Calif., Dec. 9 /PRNewswire/ -- Pathwork Diagnostics, a molecular diagnostics company focused on oncology, announced today a collaboration with Guy's and St Thomas' NHS Foundation Trust in London. Guy's and St Thomas' will be the first hospitals in the United Kingdom to conduct a research study on the Pathwork(R) Tissue of Origin Test, which aids in the diagnosis of hard-to-identify tumors.

"We're extremely excited about entering into this partnership with Guy's and St Thomas' NHS Foundation Trust," said Deborah J. Neff, President and Chief Executive Officer of Pathwork Diagnostics. "In this study, pathologists and oncologists at Guy's and St Thomas' will not only be able to validate the test for use in their institution, but more importantly, soon be able to use information generated to help them determine the most effective, cancer-specific treatment regimen for hard-to-diagnose cases."

In the collaboration, Dr. Giuseppe Culora, the clinical director, and Dr. Eugene Halligan, the scientific director, are performing a proof-of-concept validation study. "Since patients with cancer of unknown primary have a very poor prognosis, we hope that with this novel diagnostic test our oncologists will have new information at their fingertips to guide treatment and be able to offer a better standard-of-care for our cancer patients," said Dr. Culora.

The Pathwork Tissue of Origin Test uses a microarray to measure the RNA expression pattern, comprising more than 1,500 genes, in the tumor and compares it to expression patterns of a panel of 15 known tumor types, representing 60 morphologies overall, to help determine the tumor's origin. Earlier this year, Pathwork became the first U.S.-based company to receive U.S. Food and Drug Administration (FDA) clearance for a molecular diagnostics test under
'/>"/>

SOURCE Pathwork Diagnostics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Studies Investigate Diagnostic Performance and Reproducibility of Pathwork Diagnostics Tissue of Origin Test
2. Pathwork Tissue of Origin Test Shows Potential to Aid in the Diagnosis of Cancer of Unknown Primary
3. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
4. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
5. Hypertension Diagnostics Announces Fiscal Year 2007 Results
6. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
7. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
10. HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes
11. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... Hope For The Warriors® ... 2016. Scholarships are awarded two times each year to spouses or caregivers of ... nonprofit dedicated to restoring a sense of self, restoring the family unit, and ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... real estate investment landscape by connecting accredited and institutional investors to real estate ... products designed to meet demand from both investors and sponsoring real estate ...
(Date:9/3/2015)... ... ... The Linda Hall Library 2015 Fall Lecture Series will give ... at the South Pole, and the interior of life-extending stem cells – educating ... foremost independently funded research library devoted to science, engineering, and technology, will feature the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Dr. Robert Winchell has been appointed ... and Acute Care at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 27. He will serve ... renowned expert in care for the critically injured and the development, design and operations ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... upcoming virtual conference, “Proven Pharmacy Benefit Strategies for a Rapidly Changing Marketplace.” In ... Express Scripts and Milliman, will discuss how plan sponsors are adopting bold, innovative ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2
... taken necessary steps and planned a schedule to support employed ... that women took leave from work very often to take ... schedule of work and increased their stress level. ... wide rage of medical problems. The news paper said that ...
... medical marijuana, concerns have been raised by justices regarding allowing ... symptoms and perhaps even prolong life. A federal appeals court ... legal wrangling over the issue, this week. ,The ... the drug should be allowed, it is the only viable ...
... Statistics show that about one in 100 11-year-olds had taken ... and one in 10 of 15-year-olds// have taken hard drugs. ... pupils. They take illegal drugs such as cocaine which has ... , The survey was carried out among England's 3.4 million ...
... getting sensitive to noise, and do not like it much! ... noisy surroundings// may face an increased risk of suffering a ... chances of urban middle-aged adults, living on high-traffic ... percent chance of suffering heart attack, than those who lived ...
... Even though mental disorders are said to account for ... studies have been undertaken to assess// this assumption in ... as part of the WHO World Mental Health (WMH) ... 2857 adults was done in Lebanon between September, 2002, ...
... The new low nicotine Quest? cigarettes seems to have ... to a study conducted by researchers// at the Transdisciplinary ... School of Medicine.Results of the study have been published ... ,The author of this study, Caryn Lerman, PhD, Associate ...
Cached Medicine News:Health News:Cancer Patient to Appeal to SC, Demanding Right to Use Marijuana 2Health News:A National Survey Revealed That Mental Disorders Are Common In Lebanon 2
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... successfully used to save millions of lives across globe. ... the Kingdom of Saudi Arabia . ... raw material suppliers, government agencies and regulatory bodies. The ... been studied from two perspectives: by products and by ...
(Date:9/3/2015)... Sept. 3, 2015  WellCare Health Plans, Inc. (NYSE: ... , senior vice president and chief financial officer, is ... Healthcare Conference on Wednesday, September 9, 2015, at 9:25 ... webcast live. In addition, a replay of the webcast ... broadcast. Both the live broadcast and the replay will ...
(Date:9/3/2015)... RICHMOND, Va. , Sept. 3, 2015  As ... for patients with heart disease, Marc R. Katz ... of the Bon Secours Heart & Vascular Institute implanted ... August 18, 2015. The patient was selected as part ... is one of 60 elite centers in the United ...
Breaking Medicine Technology:Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4
... BERGISCH GLADBACH, Germany, May 20 Miltenyi ... Myelin Removal Beads. Myelin,is a specialized membrane ... and central nervous system. During preparation of ... contaminant. "When,dissociating adult neural tissue, usually less ...
... New data demonstrate that maintenance therapy with RISPERDAL(R) CONSTA(R) ... relapse compared to placebo in patients with Bipolar I ... at a major medical meeting. Bipolar Disorder is ... person,s mood, energy and ability to function. It is ...
Cached Medicine Technology:Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings 2RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 2RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 3RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 4RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 5RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 6RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 7RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 8RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 9RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 10
A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
Sinus Trocar and Cannula, 4 mm...
1.0 mm diameter head, 0.75 mm deep bite....
Kelly Punches...
Medicine Products: